Abbott | ABT - Nettoeinkommen

Aktienkurs
88.63
Täglich Wechseln
0.72 0.82%
Monatlich
-7.68%
Jährlich
-34.45%
Q2 Prognose
82.77




Nettoeinkommen Veränderung Datum
Abbott USD 1.08B 699M 2026-03
Agilent USD 305M 129M 2025-12
AtriCure USD 108K 1.65M 2026-03
Baxter International USD -15M 1.11B 2026-03
Becton, Dickinson and Co. USD -311M 693M 2026-03
Bio-Rad Laboratories USD 720M 1.06B 2025-12
Boston Scientific USD 1.34B 669M 2026-03
Cooper Companies USD 130.8M 46.2M 2025-12
Danaher USD 1.03B 168M 2026-03
Dexcom USD 199.5M 67.8M 2026-03
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Globus Medical USD 140.59M 21.63M 2025-12
Insulet USD 91.1M 10.5M 2026-03
Integra LifeSciences USD -4.62M 2.91M 2026-03
Intuitive Surgical USD 821.5M 26.7M 2026-03
J&J USD 5.24B 119M 2026-03
Masimo USD 57.1M 11.2M 2026-03
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 41M 2.99M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Smith & Nephew USD 293M 79M 2025-12
Solventum Corp USD 13M 50M 2026-03
Stryker USD 745M 104M 2026-03
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -8.15M 706.18M 2026-03
Terumo JPY 26.37B 6.28B 2026-03
Thermo Fisher Scientific USD 1.65B 313M 2026-03
Zimmer Biomet Holdings USD 238.1M 98.8M 2026-03